REQUEST A DEMO
Total
USD $0.00
Search more companies

Pt Merck Tbk (Indonesia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Pt Merck Tbk Profile Updated: October 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

PT. Merck Indonesia Tbk. (MERK) operates in the pharmaceutical and chemical business in Indonesia. In pharmaceutical, the company manufactures the following products: Neurobion®, Sangobion® and Glucophage®. While in chemical business, MERK markets a whole range of laboratory reagents, pigments and other specialty chemicals. MERK was listed on Indonesia Stock Exchange in 1981 under the Development Board. The company was founded in 1970 and based in Jakarta, Indonesia. MERK operates as a subsidiary of Merck KGaA, a pharmaceutical company based in Darmstadt, Germany.

Headquarters
Jl Tb Simatupang, No 8, Pasar Rebo
Jakarta; Jakarta; Postal Code: 13760

Contact Details: Purchase the Pt Merck Tbk report to view the information.

Website: http://www.merck.co.id

Basic Information
Total Employees:
Purchase the Pt Merck Tbk report to view the information.
Outstanding Shares:
Purchase the Pt Merck Tbk report to view the information.
Financial Auditors:
Purchase the Pt Merck Tbk report to view the information.
Incorporation Date:
1970
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
73.99%
Purchase this report to view the information.
12.66%
Company Performance
Financial values in the chart are available after Pt Merck Tbk report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IDR. Absolute financial data is included in the purchased report.
Net sales revenue
-5.42%
Total operating revenue
-6.45%
Operating profit (EBIT)
-46.12%
EBITDA
-42.32%
Net Profit (Loss) for the Period
-48.34%
Total assets
8.37%
Total equity
-0.78%
Operating Profit Margin (ROS)
-11.14%
Net Profit Margin
-8.32%
Return on Equity (ROE)
-6.2%
Debt to Equity Ratio
0.29%
Quick Ratio
-0.52%
Cash Ratio
-0.44%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?